Virology News and Research

Latest Virology News and Research

Prevention of cervical cancer in Latin America

The latest Special Issue from ecancermedicalscience collects four new research articles on the topic of cervical cancer prevention in Latin America.

12 Oct 2015

Role for endogenous retrovirus proposed in ALS pathogenesis

Expression of the human endogenous retrovirus-K is upregulated in some patients with sporadic amyotrophic lateral sclerosis and causes degeneration of motor neurons when overexpressed in mice, research shows.

9 Oct 2015

Safety and immunogenicity clinical trial of Ebola vaccine regimen starts in Sierra Leone

Johnson & Johnson today announced the start of a safety and immunogenicity clinical trial in Sierra Leone of a preventive Ebola vaccine regimen in development at its Janssen Pharmaceutical Companies.

9 Oct 2015

Volunteer nurse back in isolation with Ebola complications

This morning Pauline Cafferkey, the nurse who survived infection with the Ebola virus, was airlifted to an isolation unit at the Royal Free Hospital in London after the Ebola virus was detected in blood samples.

9 Oct 2015

New national report on use of antiviral drugs to treat, prevent influenza

A major new national report into the use of antiviral drugs (neuraminidase inhibitors) to treat and prevent influenza has drawn heavily on two pieces of research undertaken at The University of Nottingham.

9 Oct 2015

Lonza, Benitec partner to develop scalable manufacturing process for AAV-based viral gene therapies

Lonza Houston, Inc., a global leader in biological, cell and viral gene therapy manufacturing, and Benitec Biopharma, a clinical stage biotechnology company commercializing a patented gene-silencing technology, DNA-directed RNA interference (ddRNAi), today announced that they have entered into a Manufacturing Services Agreement to develop a scalable manufacturing process for Benitec's ddRNAi-based, Adeno-Associated Virus (AAV)-delivered products intended for therapeutic use in humans.

7 Oct 2015

New studies suggest ways to improve cancer care by inhibiting oncogenes, boosting tumor-suppressor activity

Two new studies by cancer scientists at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) suggest new approaches for treating cancer by inhibiting overactive cancer-promoting genes and by enhancing the activity of sluggish tumor-suppressor genes.

7 Oct 2015

Rabbit virus can be paired with existing drug to deliver more potent punch to brain tumor cells

A rabbit virus currently being developed for cancer therapy can be paired with one of several existing drugs to deliver a more potent punch to a deadly type of brain tumor cell, researchers have found.

7 Oct 2015

NS1 protein can be considered as vital target for development of new drugs to treat dengue: Study

Dengue is a mosquito-borne tropical disease currently endemic in more than 10 countries. According to the World Health Organization, 390 million people are infected by dengue every year.

7 Oct 2015

Researchers find link between El Niño and dengue epidemics

Epidemics of dengue are linked to high temperatures brought by the El Niño weather phenomenon, a University of Florida scientist working with an international team of researchers has found.

7 Oct 2015

Flu vaccine significantly reduces stroke risk

The risk of suffering a stroke is significantly reduced for up to two months after receiving a flu vaccine, a major new study has shown.

6 Oct 2015

NIH-funded researchers test new gene therapy to improve visual function in mice

Researchers funded by the National Institutes of Health have developed a novel mouse model for the vision disorder Leber hereditary optic neuropathy (LHON), and found that they can use gene therapy to improve visual function in the mice. LHON is one of many diseases tied to gene mutations that damage the tiny energy factories that power our cells, called mitochondria.

6 Oct 2015

New smartphone-based device can reliably perform molecular diagnoses at low cost

NIBIB-funded researchers at the Massachusetts General Hospital have developed a smartphone-based device that can reliably carry out molecular diagnoses in under an hour for approximately two dollars per patient. The device could enable point-of-care cancer diagnostics in low- to middle-income or remote areas, which often have high rates of mortality from cancer due to missed opportunities for treatment.

6 Oct 2015

Understanding HCV disease progression rates among PWID

The Hepatitis C virus (HCV) infection is a chronic blood-borne viral infection that affects an estimated 160 million people, or 2-3% of the population world-wide. Alarmingly, chronic HCV infection accounts for one-quarter of the cases of cirrhosis and hepatocellular carcinoma (HCC). If HCV is left untreated, chronic liver disease will occur in 60-70% of the cases, cirrhosis in 5-20% of the cases, and 1-5% will die from decompensated cirrhosis or HCC.

6 Oct 2015

Paradigm failure is primary reason for lack of progress in cancer research, says cancer biologist

A recent publication, which received sustained media attention, claimed that most cancers are just “bad luck”. Its authors stated that only about one-third of cancer mutations are caused by known lifestyle or environmental factors.

6 Oct 2015

New test capable of detecting all viruses that affect people and animals

A new, super-sensitive test has been developed that can detect virtually any virus that causes illness in humans and animals, according to researchers at Washington University School of Medicine in St. Louis.

1 Oct 2015

Two studies identify promising new anti-retroviral strategy to combat HIV-1

A pair of studies by researchers at the University of Massachusetts Medical School, the University of Trento in Italy, and the University of Geneva in Switzerland, point to a promising new anti-retroviral strategy for combating HIV-1.

1 Oct 2015

Health Partnership Scheme funds project dedicated to viral haemorrhagic fever

A team from Plymouth University Peninsula Schools of Medicine and Dentistry and Plymouth Hospitals NHS Trust has received funding of £136,000 from the Health Partnership Scheme to develop a training programme to help the Sierra Leonean Health Service to fight future outbreaks of viral haemorrhagic fever.

1 Oct 2015

Coalition unions, Kaiser Permanente sign landmark contract to protect health care workers and patients from flu

A coalition of unions representing Kaiser Permanente health care workers in the nation's largest private sector talks this year have ratified a landmark agreement that includes a jointly developed flu vaccination policy for health care workers who deal directly with patients.

30 Sep 2015

Generex agrees to acquire 51% equity interest in Hema Diagnostic Systems

Generex Biotechnology Corporation today announced that it has entered into a non-binding Letter of Intent (LOI) with Hema Diagnostic Systems, LLC (HDS), a Florida company that designs and manufactures proprietary infectious disease detection technologies.

30 Sep 2015

Virology News and Research

Latest Virology News and Research

Prevention of cervical cancer in Latin America

Role for endogenous retrovirus proposed in ALS pathogenesis

Safety and immunogenicity clinical trial of Ebola vaccine regimen starts in Sierra Leone

Volunteer nurse back in isolation with Ebola complications

New national report on use of antiviral drugs to treat, prevent influenza

Lonza, Benitec partner to develop scalable manufacturing process for AAV-based viral gene therapies

New studies suggest ways to improve cancer care by inhibiting oncogenes, boosting tumor-suppressor activity

Rabbit virus can be paired with existing drug to deliver more potent punch to brain tumor cells

NS1 protein can be considered as vital target for development of new drugs to treat dengue: Study

Researchers find link between El Niño and dengue epidemics

Flu vaccine significantly reduces stroke risk

NIH-funded researchers test new gene therapy to improve visual function in mice

New smartphone-based device can reliably perform molecular diagnoses at low cost

Understanding HCV disease progression rates among PWID

Paradigm failure is primary reason for lack of progress in cancer research, says cancer biologist

New test capable of detecting all viruses that affect people and animals

Two studies identify promising new anti-retroviral strategy to combat HIV-1

Health Partnership Scheme funds project dedicated to viral haemorrhagic fever

Coalition unions, Kaiser Permanente sign landmark contract to protect health care workers and patients from flu

Generex agrees to acquire 51% equity interest in Hema Diagnostic Systems

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production